E2f-1 induced apoptosis

Apoptosis

Volumn 6, Issue 3, 2001, Pages 173-182

  Phillips, A C ^a   Vousden, K H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Cell cycle; E2F1; p53

Indexed keywords

PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHEMOSENSITIVITY; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0035014564     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011332625740     Document Type: Article

References (112)

1. The regulation of E2F by pRB-family proteins
2. Regulation of E2F1 activity by acetylation
3. E2F family members are differentially regulated by reversible acetylation
4. Retinoblastoma protein recruits histone deacetylase to repress transcription
5. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase
6. Rb interacts with histone deacetylase to repress transcription
7. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
8. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry
9. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression
10. Control of pRB phosphorylation
11. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway
12. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
13. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
14. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
15. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis
16. Multiple members of the E2F transcription factor family are the products of oncogenes
17. The transcriptional factor E2F is required for S phase during Drosophila embryogenesis
18. Genetic alterations of cyclins, cyclin dependent kinases and cdk inhibitors in human cancers
19. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
20. E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway
21. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis
22. E2F-6: A novel member of the E2F family is an inhibitor of E2F-dependent transcription
23. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6
24. E2F-6, a member of the E2F family that can behave as a transcriptional repressor
25. INK4A-mediated growth suppression
26. Distinct roles for E2F proteins in cell growth control and apoptosis
27. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members
28. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal
29. The subcellular localization of E2F-4 is cell-cycle dependent
30. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization
31. E2F activity is regulated by cell cycle-dependent changes in subcellular localization
32. E2F4 is essential for normal erythrocyte maturation and neonatal viability
33. E2f3 is critical for normal cellular proliferation
34. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting
35. Loss of E2F4 activity leads to Abnormal development of Multiple Cellular Lineages
36. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control
37. E2F-1 functions in mice to promote apoptosis and suppress proliferation
38. Tumor induction and tissue atrophy in mice lacking E2F-1
39. Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts
40. Retinoblastoma: The disease, gene and protein provide critical leads to understand cancer
41. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
42. Effects of an Rb mutation in the mouse
43. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle
44. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis
45. Transcriptional control by the retinoblastoma protein
46. Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
47. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model
48. E2F4 E2F1 have similar proliferative properties but different apoptotic oncogenic properties in vivo
49. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
50. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
51. E2F and cell proliferation: A world turned upside down
52. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice
53. p53-dependent apoptosis suppresses tumor growth and progression in vivo
54. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors
55. Death receptors: Signaling and modulation
56. Mitochondria and apoptosis
57. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
58. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
59. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
60. TRADD signals cell death and NF-kB activation
61. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
62. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF
63. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-κB activation
64. E2F-1 potentiates cell death by blocking anti-apoptotic signaling pathways
65. The cellular response to p53: The decision between life and death
66. Role for the p53 homolog p73 in E2F1-induced apoptosis
67. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation
68. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
69. p53 mutations in human cancers
70. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
71. Mdm2 promotes the rapid degradation of p53
72. Regulation of p53 stability by Mdm2
73. Stress signals utilize multiple pathways to stabilize p53
74. ARF links the tumour suppressors RB and p53
75. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
76. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
77. ARF, participates in a regulatory feedback loop with p53 and MDM2
78. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
79. E1A signaling to p53 involves the p19(ARF) tumor suppressor
80. p19ARF links the tumour suppressor p53 to Ras
81. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
82. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection
83. A role for E2F1 in the induction of apoptosis during thymic negative selection
84. The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF)
85. Mdm2 binds p73α without targeting degradation
86. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
87. MDM2 and MDMX bind and stabilize the p53-related protein p73
88. MDM2 suppresses p73 function without promoting p73 degradation
89. Regulation of the cell cycle by viral oncoproteins
90. Use of the E2F transcription factor by DNA tumor virus regulatory proteins
91. Viruses and apoptosis
92. p53 and E2F-1 cooperate to mediate apoptosis
93. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis
94. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
95. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system
96. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
97. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
98. Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis
99. Role of E2F-1 in chemosensitivity
100. In vivo radiosensitizing effect of the adenovirus E1A gene in murine and human malignant tumors
101. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway
102. Suppression of TNFα induced apoptosis by NF-kB
103. TNF- and cancer therapy induced apoptosis: Potentiation by inhibition of NF-kB
104. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53
105. Increased levels of E2F-1-dependent DNA binding activity after UV- or gamma-irradiation
106. Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb
107. Apoptotic and growth-promoting activity of E2F modulated by MDM2
108. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation
109. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
110. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint
111. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
112. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion